NYSEAMERICAN:ATNM - Actinium Pharmaceuticals Price Target & Analyst Ratings

$0.24
0.00 (0.00 %)
(As of 07/18/2019 04:00 PM ET)
Today's Range
$0.23
Now: $0.2352
$0.2360
50-Day Range N/A
52-Week Range
$0.23
Now: $0.2352
$0.87
Volume342,206 shs
Average Volume1.13 million shs
Market Capitalization$38.11 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Analyst Ratings

Actinium Pharmaceuticals (NYSEAMERICAN:ATNM) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
4 Wall Street analysts have issued ratings and price targets for Actinium Pharmaceuticals in the last 12 months. Their average twelve-month price target is $4.25, suggesting that the stock has a possible upside of 1,706.97%. The high price target for ATNM is $6.00 and the low price target for ATNM is $3.00. There are currently 4 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.003.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $4.25$4.25$4.25$4.25
Price Target Upside: 1,706.97% upside1,417.86% upside672.73% upside733.33% upside

Actinium Pharmaceuticals (NYSEAMERICAN:ATNM) Consensus Price Target History

Actinium Pharmaceuticals (NYSEAMERICAN:ATNM) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetDetails
6/4/2019Maxim GroupSet Price TargetBuy$3.00View Rating Details
2/26/2019OppenheimerSet Price TargetBuy$5.00View Rating Details
12/4/2018Roth CapitalSet Price TargetBuy$6.00View Rating Details
8/15/2018B. RileySet Price TargetBuy$3.00View Rating Details
10/23/2017HC WainwrightReiterated RatingBuy$6.00View Rating Details
(Data available from 7/18/2017 forward)
This page was last updated on 7/18/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel